Breaking News Instant updates and real-time market news.

VWO

Vanguard FTSE Emerging Markets ETF

$43.19

(0.00%)

, EDU

New Oriental Education

$105.76

(0.00%)

09:40
06/20/18
06/20
09:40
06/20/18
09:40

Unusually active option classes on open June 20th

Unusual total active option classes on open include: Vanguard MSCI Emerging Markets (VWO), New Oriental Education (EDU), Starbucks (SBUX), Denbury Resources (DNR), Walgreen Boots (WBA), Fedex (FDX), IQ (IQ), Alphabet Class A (GOOGL), S&P 500 Index (.SPX), and General Electric (GE).

VWO

Vanguard FTSE Emerging Markets ETF

$43.19

(0.00%)

EDU

New Oriental Education

$105.76

(0.00%)

SBUX

Starbucks

$57.43

(0.00%)

DNR

Denbury Resources

$4.12

(0.00%)

WBA

Walgreens Boots Alliance

$64.61

(0.00%)

FDX

FedEx

$258.35

(0.00%)

IQ

iQIYI

$42.58

(0.00%)

GOOGL

Alphabet Class A

$1,178.29

(0.00%)

SPX

S&P 500

$0.00

(0.00%)

GE

General Electric

$12.96

(0.00%)

  • 22

    Jun

  • 28

    Jun

  • 19

    Aug

  • 10

    Sep

  • 20

    Sep

  • 21

    Sep

VWO Vanguard FTSE Emerging Markets ETF
$43.19

(0.00%)

EDU New Oriental Education
$105.76

(0.00%)

03/05/18
JPMS
03/05/18
UPGRADE
Target $83
JPMS
Neutral
New Oriental Education upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Leon Chik upgraded New Oriental Education to Neutral and raised his price target for the shares to $83 from $72. The analyst attributes the 10% pullback in shares last week to concerns over tighter regulations on tutorials in China. He believes, however, that large operators like New Oriental can comply with government regulations better than their smaller rivals The company can continue to obtain new tutorial licenses and grow at a "rapid pace," Chik tells investors in a research note.
01/04/18
DBAB
01/04/18
INITIATION
Target $116
DBAB
Buy
New Oriental Education initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Tallan Zhou started New Oriental Education with a Buy rating and $116 price target. The analyst sees positive demographic growth in China, an increased number of wealthy families, and greater education awareness as demand drivers.
05/24/18
LYON
05/24/18
DOWNGRADE
LYON
Underperform
New Oriental Education downgraded to Underperform from Outperform at CLSA
06/14/18
JEFF
06/14/18
NO CHANGE
Target $42.5
JEFF
Buy
Jefferies keeps Buy rating on TAL, says fraud claims are serious
While Muddy Waters' report did not relate to TAL Education's (TAL) core businesses, the fraud claims are serious nonetheless and would cast concerns over the company's integrity should management be unable to provide a satisfactory explanation, Jefferies analyst Johnny Kin Man Wong tells investors in a research note. The analyst expects share price volatility and notes that New Oriental Education's (EDU) stock price fell from $22.26 to $9.47, or 57.5%, over the course of two days when similar short reports arose in July 2012. Wong has a Buy rating on TAL Education with a $42.50 price target.
SBUX Starbucks
$57.43

(0.00%)

06/20/18
BMOC
06/20/18
NO CHANGE
Target $56
BMOC
Market Perform
Starbucks price target lowered to $56 at BMO Capital on reduced comps and EPS
BMO Capital analyst Andrew Strelzik lowered his price target on Starbucks to $56 from $58 after the company lowered its Q3 comps and FY18 EPS outlook while also increasing its capital return target and announced some store closures. The analyst also cut his FY18 EPS view to $2.40 from $2.50 while keeping his Market Perform rating, stating that he will await greater visibility into sustained comps improvement following yesterday's announcement. Strelzik adds that it is "difficult to have confidence in the sustainability of comps", especially given that Starbucks may have benefited from earlier price increases relative to last year.
06/20/18
UBSW
06/20/18
NO CHANGE
Target $66
UBSW
Buy
UBS keeps Buy rating, $66 price target on Starbucks after growth plans announced
UBS analyst Dennis Geiger noted Starbucks released preliminary, and light, global same-store sales and lowered its full year guidance, while also announcing expectations for up to 150 store closures. The analyst also noted the company announced plans to accelerate growth through tangible sales drivers and streamlined operations while keeping long-term guidance unchanged. Geiger maintained his Buy rating and $66 price target on Starbucks shares.
06/20/18
06/20/18
DOWNGRADE
Target $59

Equal Weight
Morgan Stanley questions if Starbucks doing enough, downgrades to Equal Weight
As previously reported, Morgan Stanley analyst John Glass downgraded Starbucks to Equal Weight from Overweight after the company announced a same-store sales shortfall and cut its FY18 guidance. While the company announced plans for product and digital innovation in reaction to "what is now a clearer pattern of slower U.S. sales," Glass said it is hard to see how much those will impact sales. U.S. unit growth also is being slowed temporarily, but Glass thinks more action on this front may be warranted, he tells investors. China deceleration was a "negative surprise," and believing in the long-term opportunity there is important to the long-term thesis, added the analyst, who lowered his price target on Starbucks shares to $59 from $72. The stock was also downgraded to Neutral at BTIG and to Market Perform at Telsey Advisory this morning.
06/20/18
LEHM
06/20/18
NO CHANGE
Target $60
LEHM
Equal Weight
Starbucks price target lowered to $60 from $65 at Barclays
Barclays analyst Jeffrey Bernstein lowered his price target for Starbucks to $60 saying the company last night preannounced "disappointing" Q3 global comps and reduced fiscal 2018 guidance. The analyst is surprised by the comp shortfall given that management expressed confidence in April on a second half of fiscal 2018 comp re-acceleration. While happy to see the steps towards maturation, the brand continues to set a high bar of outsized "growth at scale," which will continue to prove challenging, Bernstein tells investors in a research note. He keeps an Equal weight rating on Starbucks.
DNR Denbury Resources
$4.12

(0.00%)

03/07/18
UBSW
03/07/18
INITIATION
Target $2.5
UBSW
Neutral
Denbury Resources initiated with a Neutral at UBS
UBS analyst Lloyd Byrne started Denbury Resources with a Neutral rating and $2.50 price target.
01/16/18
MZHO
01/16/18
UPGRADE
MZHO
Buy
Denbury Resources upgraded to Buy from Neutral at Mizuho
05/14/18
KLRG
05/14/18
DOWNGRADE
Target $4
KLRG
Hold
Denbury Resources downgraded to Hold from Buy at KLR Group
KLR Group analyst Gail Nicholson downgraded Denbury Resources to Hold from Buy citing valuation after the stock has significantly outperformed year-to-date. Nicholson raised her price target on Denbury shares to $4.00 from $3.25.
10/03/17
IMPC
10/03/17
INITIATION
Target $2
IMPC
In-Line
Denbury Resources initiated with an In-Line at Imperial Capital
Imperial Capital analyst Jason Wangler started Denbury Resources with an In-Line rating and $2 price target.
WBA Walgreens Boots Alliance
$64.61

(0.00%)

05/29/18
MZHO
05/29/18
NO CHANGE
Target $77
MZHO
Buy
Walgreens Boots Alliance price target lowered to $77 from $87 at Mizuho
Mizuho analyst Ann Hynes views Walgreens Boots Alliance's sell-side event last week as "strange." Management highlighted the company was focused on a new strategy for the stores, but would not share any details on the strategy for competitive reasons, Hynes tells investors in a research note. The analyst, however, keeps a Buy rating on the shares citing Walgreens' current valuation, "strong" cash flow and likely limited downside risk to adjusted earnings estimates.
05/23/18
LEER
05/23/18
NO CHANGE
Target $70
LEER
Market Perform
Walgreens Boots Alliance price target lowered to $70 from $75 at Leerink
Leerink analyst David Larsen lowered his price target for Walgreens Boots Alliance to $70 from $75 as healthcare hub strategy is taking time and headwinds continue. The analyst reiterates a Market Perform rating on the shares.
04/24/18
LEER
04/24/18
NO CHANGE
LEER
Amazon shelving pharma supply efforts to hospitals not surprising, says Leerink
Leerink analyst David Larsen notes that Amazon (AMZN) is said to be shelving its pharmaceutical supply efforts to hospitals, which he does not see as a suprise given several barriers to entry. The consumer market has always been Amazon's core competency, though he expects it will be a long, gradual, and difficult process of building up an online drug portfolio with an initial focus likely on generics. The analyst believes the risk of Amazon entering retail in the near term is reduced significantly. Nonetheless, Larsen thinks risk remains longer term for retail pharmacies such as CVS (CVS) and Walgreens Boots Alliance (WBA).
04/17/18
MZHO
04/17/18
NO CHANGE
MZHO
Amazon news removes 'unprecedented overhang' on drug sellers, says Mizuho
After CNBC reported yesterday afternoon that Amazon (AMZN) has decided to shelve its plan to sell and distribute pharmaceutical products, Mizuho analyst Ann Hynes said she had thought Amazon's current logistics and distribution model would not translate into healthcare. However, based on conversations with investors, she believes the magnitude of the overhang that Amazon presented for drug distributors and retail pharmacies was "unprecedented." While drug pricing is still a concern, she notes that the CNBC report removes one overhang on the drug supply chain stocks. Hynes remain a buyer of CVS Health (CVS) and Walgreens (WBA) and keeps Neutral ratings on Rite Aid (RAD) as well as on drug distributors AmerisourceBergen (ABC), Cardinal Health (CAH) and McKesson (MCK).
FDX FedEx
$258.35

(0.00%)

06/20/18
SPHN
06/20/18
NO CHANGE
Target $306
SPHN
Overweight
FedEx 'cleared decks' with FY19 guidance, says Stephens
Stephens analyst Jack Atkins believes FedEx's initial FY19 EPS guidance was in-line with or slightly ahead of buy-side expectations and that the "decks are now cleared" to focus on the significant earnings potential he sees in the business. Atkins, who believes FedEx has earnings power of over $20 per share in FY20, keeps an Overweight rating and $306 price target on the stock.
06/20/18
BARD
06/20/18
NO CHANGE
Target $280
BARD
Outperform
FedEx positions should be trimmed into strength, says Baird
Baird analyst Benjamin Hartford said he still likes FedEx's positioning given its visibility to a rising return-on-capital and cash flow profile over time. However, near-term catalysts appear limited given the incremental macroeconomic cycle and trade risks and a still constrained free cash flow profile that keeps him cautious near-term. The analyst recommends trimming positions into strength, but would be a more aggressive buyer near the $240 level. Hartford maintains his Outperform rating and $280 price target on FedEx shares.
06/20/18
MSCO
06/20/18
NO CHANGE
MSCO
Equal Weight
FedEx guidance looks 'soft,' cash flow concerns to linger, says Morgan Stanley
Morgan Stanley analyst Ravi Shanker said FedEx's Q4 EPS beat expectations, but the "quality was not great." Additionally, FY19 guidance missing by 1% at the midpoint may have been expected, but the "details are likely to disappoint," according to Shanker. While bulls may be relieved that FY19 capex guidance declined year-over-year, the relief is likely to be short-lived and free cash flow concerns are likely to continue as management warned of capex spiking in FY20 and FY21, added the analyst, who keeps an Equal Weight rating on FedEx shares.
06/20/18
SBSH
06/20/18
NO CHANGE
Target $304
SBSH
Buy
FedEx results 'good enough' given investor concerns, says Citi
Citi analyst Christian Wetherbee says FedEx's Q4 results and outlook were basically right in line with expectations, which he believes is "good enough" given investor concerns toward quarter end. The company continues to enjoy tailwinds to its business from e-commerce growth and favorable comps from last year's cyber-attack, Wetherbee tells investors in a research note. He continues to see a path to $20 in fiscal 2020 earnings per share and keeps a Buy rating on FedEx with a $304 price target.
IQ iQIYI
$42.58

(0.00%)

05/08/18
05/08/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Juniper (JNPR) initiated with a Neutral at Rosenblatt. 2. Nice Systems (NICE) initiated with an Equal Weight at Morgan Stanley. 3. Mersana Therapeutics (MRSN) initiated with an Outperform at Baird. 4. iQIYI (IQ) initiated with a Buy at Goldman Sachs. 5. Cubic (CUB) initiated with an Outperform at William Blair. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/08/18
GSCO
05/08/18
INITIATION
Target $23
GSCO
Buy
iQIYI initiated with a Buy at Goldman Sachs
Goldman analyst Piyush Mubayi initiated iQIYI with a Buy and $23 price target.
04/25/18
BOFA
04/25/18
INITIATION
Target $21
BOFA
Neutral
iQIYI initiated with a Neutral at BofA/Merrill
BofA/Merrill analyst Eddie Leung initiated iQIYI with a Neutral and $21 price target due to valuation.
04/24/18
SBSH
04/24/18
INITIATION
Target $22
SBSH
Buy
iQIYI initiated with a Buy at Citi
Citi started iQIYI with a Buy rating and $22 price target.
GOOGL Alphabet Class A
$1,178.29

(0.00%)

06/20/18
GSCO
06/20/18
DOWNGRADE
Target $37
GSCO
Sell
Alarm.com downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Gabriela Borges downgraded Alarm.com (ALRM) to Sell and lowered her price target for the shares to $37 from $41. The analyst's analysis indicates that new "Do it Yourself" deployments with professional monitoring are 35% cheaper than professionally installed and monitored security systems. This creates risk to subscriber growth and unit economics in the existing home security ecosystem, which drives the majority of Alarm.com's business, Borges tells investors in a research note. Further, the analyst believes the Amazon (AMZN) versus Google (GOOG, GOOGL) battle for dominance in the connected home will likely cap Alarm.com's ability to expand beyond its core market. She finds Alarm.com's risk/reward unfavorable at current valuations.
06/19/18
WELS
06/19/18
NO CHANGE
Target $53
WELS
Outperform
JD.com price target raised to $53 from $47 at Wells Fargo
Wells Fargo analyst Ken Sena raised his price target for JD.com (JD) to $53 from $47 after the company and Google (GOOG; GOOGL) announced that the latter will invest $550M in cash in JD.com as part of a strategic partnership. The analyst believes this partnership adds to JD's strong list of existing data and strategic partnerships with Tencent (TCEHY), Walmart (WMT), Baidu (BIDU), Qihoo 360 and Vipshop (VIPS). Sena reiterates an Outperform rating on JD.com shares.
06/18/18
CHLM
06/18/18
NO CHANGE
Target $120
CHLM
Buy
Weight Watchers price target raised to $120 from $100 at Craig-Hallum
Craig-Hallum analyst Alex Fuhrman raised his price target for Weight Watchers (WTW) to $120 from $100 as TV advertising campaign kicks off with new commercial launch. The analyst also believes Google (GOOG; GOOGL) searches are set to meaningfully accelerate and will likely move the stock higher before Q2 results are reported. Fuhrman reiterates a Buy rating on Weight Watchers shares.
06/18/18
SBSH
06/18/18
NO CHANGE
SBSH
Buy
Citi sees potential Q2 upside for Alphabet
Checks with two leading digital marketing agencies suggest growth in Google search spend remained strong in Q2, Citi analyst Mark May tells investors in a research note. The analyst believes there could be modest upside to consensus revenue forecasts and keeps a Buy rating on Alphabet shares.
SPX S&P 500
$0.00

(0.00%)

01/23/18
BOFA
01/23/18
NO CHANGE
BOFA
S&P 500 2018 year target raised to 3,000 from 2,800 at BofA/Merrill
04/02/18
MSCO
04/02/18
NO CHANGE
MSCO
Utilities view lowered to Equal Weight at Morgan Stanley
Morgan Stanley equity strategist Michael Wilson said he thinks many of the risks facing the market have now been priced in and he sees value in the S&P, which is currently at the low end of his target near-term range ahead of what will likely be a strong Q1 earnings season. However, he is moving the Utilities sector to Equal Weight from Overweight, stating that this is not a sell call for those who recently bought the stocks but that a tactical overweight after recent relative outperformance no longer makes sense.
12/11/17
OPCO
12/11/17
NO CHANGE
OPCO
Oppenheimer initiates S&P 500 price target of $3,000 in 2018 on outlook
Oppenheimer has initiated an S&P 500 price target of $3,000 in 2018 as it believes the fundamentals - both economic growth and corporate earnings - will likely improve further in 2018. Its price target and earnings estimate do not include any assumptions about what tax reform might ultimately look like.
GE General Electric
$12.96

(0.00%)

06/04/18
JPMS
06/04/18
NO CHANGE
Target $11
JPMS
Underweight
General Electric needs $30B in cash, JPMorgan's Tusa says
JPMorgan analyst Stephen Tusa says he's watching for General Electric's new board and management to set the longer-term path for a "new GE" as the company's CEO transition approaches its one-year anniversary. In a research note titled "Will The Page Officially Turn In June?," Tusa argues that investors "deserve clarity on the path forward" following "mixed messages" and the debate around portfolio value. The analyst continues to see the need for GE to "de-risk substantially," which he believes includes the need for cash and a cut to the dividend. This is not only about survival, but positioning the company to, as CEO Flannery put it recently, "flourish," Tusa writes. The analyst's preliminary math shows the need for $30B in cash to get to 2.5 times leverage as per ratings agencies. Tusa keeps an Underweight rating on General Electric with an $11 price target.
06/01/18
UBSW
06/01/18
NO CHANGE
Target $16
UBSW
Neutral
General Electric can cover dividend into 2019, says UBS
UBS analyst Steven Winoker noted investors are concerned about General Electric's ability to pay its dividend. The analyst believes the company can generate enough cash and maintain a strong credit rating if they can execute asset sales. He believes the company can cover the dividend in 2018 and 2019 and most likely into 2020, but argues a bigger free cash flow cushion is warranted. Winoker maintained his Neutral rating and $16 price target on General Electric shares.
05/30/18
JPMS
05/30/18
NO CHANGE
Target $11
JPMS
Underweight
GE Capital remains 'underappreciated risk,' says JPMorgan
JPMorgan analyst Stephen Tusa believes GE Capital "remains an underappreciated risk." In a new research note titled "GECS: Not Gone and Not to Be Forgotten; Part 3, Recent Disclosure Suggests Further Action Needed to 'De-Risk," Tusa says the math suggests more capital may be needed, even without another charge from lingering liabilities. The analyst sees either $22B in incremental asset wind down versus the standing plan, or a $3B capital contribution. While many investors are discounting January's Insurance charge as one of the last "shoes to drop," it is "more of a wake-up call around a GECS book that continues to operate with the burden of a systemic approach to making short-term earnings look better with ultimately uneconomic long-term moves," Tusa writes. He has an Underweight rating on General Electric with an $11 price target.
06/20/18
WBLR
06/20/18
NO CHANGE
WBLR
Outperform
GE's 'here to stay,' William Blair says after headquarter visit
Following a visit to General Electric's corporate headquarters in Boston late last week, William Blair analyst Nicholas Heymann believes the company's transformation, deleveraging and fundamentals "remain solidly on track." The analyst walked away with a "sense of optimism with continued progress" on GE's plan to optimize asset sale proceeds to enable it to deleverage its balance sheet to 2.5 times net debt/EBITDA. While no specific date has been provided for achieving this, the math from industrial asset sale proceeds and GE Capital portfolio liquidations would suggest year-end 2019, Heymann tells investors in a research note partially titled "GE's Here to Stay." The analyst believes GE is "reaching an inflection point for investor sentiment" and keeps an Outperform rating on the shares. He believes the stock is likely to offer "material upside potential over the near and intermediate time horizon." Shares of General Electric are down 6c to $12.89 in early trading after being last night's announcement of its removal from the Dow Jones Industrial Average.

TODAY'S FREE FLY STORIES

JPM

JPMorgan

$117.18

-0.66 (-0.56%)

11:38
09/24/18
09/24
11:38
09/24/18
11:38
Hot Stocks
JPMorgan's Dimon says hasn't spoken to president since election comments »

JPMorgan CEO Jamie Dimon,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 26

    Sep

  • 28

    Sep

  • 12

    Oct

  • 21

    Oct

  • 26

    Feb

MDT

Medtronic

$98.36

0.51 (0.52%)

11:36
09/24/18
09/24
11:36
09/24/18
11:36
Hot Stocks
Medtronic announces five-year data with CoreValve TAVR system »

Medtronic announced new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 26

    Sep

  • 09

    Oct

11:35
09/24/18
09/24
11:35
09/24/18
11:35
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

11:34
09/24/18
09/24
11:34
09/24/18
11:34
General news
3-Month Bill Auction Total Amount data reported »

3-Month Bill Auction…

11:34
09/24/18
09/24
11:34
09/24/18
11:34
General news
6-Month Bill Auction Total Amount data reported »

6-Month Bill Auction…

ERIC

Ericsson

$8.91

0.12 (1.37%)

11:32
09/24/18
09/24
11:32
09/24/18
11:32
Hot Stocks
Ericsson secures CBRS certification from FCC »

Ericsson announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$37.76

0.075 (0.20%)

11:30
09/24/18
09/24
11:30
09/24/18
11:30
Hot Stocks
AstraZeneca says European Commission grants marketing authorization for Imfinzi »

AstraZeneca and MedImmune…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$11.67

-0.505 (-4.15%)

11:30
09/24/18
09/24
11:30
09/24/18
11:30
Options
Flurry of activity in GE calls as shares fall to multi-year lows »

Flurry of activity in GE…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

11:30
09/24/18
09/24
11:30
09/24/18
11:30
General news
Treasury 2-year auction outlook »

Treasury 2-year auction…

NWL

Newell Brands

$20.22

-1.61 (-7.38%)

, SHLD

Sears

$1.17

-0.115 (-8.95%)

11:25
09/24/18
09/24
11:25
09/24/18
11:25
Recommendations
Newell Brands, Sears analyst commentary  »

Newell weakness on…

NWL

Newell Brands

$20.22

-1.61 (-7.38%)

SHLD

Sears

$1.17

-0.115 (-8.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

$5.68

-0.265 (-4.46%)

11:25
09/24/18
09/24
11:25
09/24/18
11:25
Options
Fitbit call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:25
09/24/18
09/24
11:25
09/24/18
11:25
General news
Treasury announced a $40 B 4-week bill sale for Tuesday »

Treasury announced a $40…

11:25
09/24/18
09/24
11:25
09/24/18
11:25
Conference/Events
RBC Capital multi-industry analyst to hold group luncheon »

Multi-Industry Analyst…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
09/24/18
09/24
11:17
09/24/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$218.75

1.1 (0.51%)

11:16
09/24/18
09/24
11:16
09/24/18
11:16
Hot Stocks
Apple completes acquisition of Shazam »

Apple announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
09/24/18
09/24
11:16
09/24/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBY

Best Buy

$80.08

-0.56 (-0.69%)

11:15
09/24/18
09/24
11:15
09/24/18
11:15
Options
Best Buy put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
09/24/18
09/24
11:15
09/24/18
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

11:15
09/24/18
09/24
11:15
09/24/18
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

RTN

Raytheon

$202.18

-1.315 (-0.65%)

11:12
09/24/18
09/24
11:12
09/24/18
11:12
Hot Stocks
Raytheon to expand cybersecurity customer base in the Middle East »

Raytheon Company has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSA

Comcast

$35.07

-2.84 (-7.49%)

, CMCSK

Comcast

$0.00

(0.00%)

11:11
09/24/18
09/24
11:11
09/24/18
11:11
OnTheFly
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's top…

CMCSA

Comcast

$35.07

-2.84 (-7.49%)

CMCSK

Comcast

$0.00

(0.00%)

SKYAY

Sky

$0.00

(0.00%)

AVP

Avon Products

$2.41

-0.025 (-1.03%)

CZR

Caesars

$10.53

-0.25 (-2.32%)

BIO

Bio-Rad

$308.01

9.56 (3.20%)

NTNX

Nutanix

$42.73

-3.82 (-8.21%)

MSFT

Microsoft

$113.83

-0.87 (-0.76%)

VMW

VMware

$153.08

1.08 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 10

    Oct

  • 11

    Oct

  • 16

    Oct

  • 21

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 29

    Oct

  • 28

    Nov

  • 06

    Dec

  • 10

    Dec

  • 03

    Mar

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$290.60

-1.43 (-0.49%)

11:11
09/24/18
09/24
11:11
09/24/18
11:11
Periodicals
Deputy AG Rosenstein 'summoned to the White House,' MSNBC tweets »

MSNBC tweeted,…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$290.60

-1.43 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$113.66

-1.04 (-0.91%)

, ADBE

Adobe

$261.32

0.47 (0.18%)

11:09
09/24/18
09/24
11:09
09/24/18
11:09
Hot Stocks
Microsoft, Adobe, SAP announce Open Data Initiative »

The CEOs of Adobe (ADBE),…

MSFT

Microsoft

$113.66

-1.04 (-0.91%)

ADBE

Adobe

$261.32

0.47 (0.18%)

SAP

SAP

$122.23

0.59 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 21

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 28

    Nov

  • 03

    Mar

FCX

Freeport McMoRan

$14.38

-0.22 (-1.51%)

11:05
09/24/18
09/24
11:05
09/24/18
11:05
Options
Freeport McMoRan call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:05
09/24/18
09/24
11:05
09/24/18
11:05
General news
4-Week Bill Announcement Offering Amount data reported »

4-Week Bill Announcement…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.